Rein Therapeutics, Inc. Operating Lease Liability
Rein Therapeutics, Inc. (RNTX) had Operating Lease Liability of $48.00 thousand as of 2022-12-31, per its 10-K filed 2024-04-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-04-15
- 2022-12-31: Operating Lease, Liability $48.00K; Operating Lease, Liability as first filed $33.00K.
- 2021-12-31: Operating Lease, Liability $162.00K.
- 2019-12-31: Operating Lease, Liability $5.03M.
- 2019-09-30: Operating Lease, Liability $5.13M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2022-12-31 | $48.00K 10-K · filed 2024-04-15 | $33.00K 10-K · filed 2023-03-20 |
| 2021-12-31 | $162.00K 10-K · filed 2022-03-28 | |
| 2019-12-31 | $5.03M 10-K · filed 2020-03-30 | |
| 2019-09-30 | $5.13M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.23M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $5.32M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $5.40M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |